Exodus Point Capital Management, LP Savara Inc Transaction History
Exodus Point Capital Management, LP
- $9.1 Billion
- Q3 2025
A detailed history of Exodus Point Capital Management, LP transactions in Savara Inc stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 123,790 shares of SVRA stock, worth $537,248. This represents 0.0% of its overall portfolio holdings.
Number of Shares
123,790Holding current value
$537,248% of portfolio
0.0%Shares
11 transactions
Others Institutions Holding SVRA
# of Institutions
134Shares Held
161MCall Options Held
14.3KPut Options Held
24.9K-
Nea Management Company, LLC Timonium, MD24.5MShares$106 Million5.38% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA17.6MShares$76.4 Million19.88% of portfolio
-
Vr Adviser, LLC New York, NY12.7MShares$55 Million6.78% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA12.4MShares$53.7 Million4.88% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA11.5MShares$49.7 Million1.71% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $495M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.